Holen Sie sich die Stockscreener-App
1.07
1.83%
-0.02
Schlusskurs vom Vortag:
$1.09
Offen:
$1.09
24-Stunden-Volumen:
59,447
Relative Volume:
0.06
Marktkapitalisierung:
$63.84M
Einnahmen:
$8.38M
Nettoeinkommen (Verlust:
$-27.19M
KGV:
-0.9817
EPS:
-1.09
Netto-Cashflow:
$-13.59M
1W Leistung:
+0.00%
1M Leistung:
+0.94%
6M Leistung:
-6.96%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.05
$1.10
1-Wochen-Bereich:
$1.05
$1.1362
52-Wochen-Spanne:
$0.65
$1.75
Opus Genetics Inc Stock (IRD) Company Profile
Firmenname
Opus Genetics Inc
Sektor
Branche
Telefon
248-681-9815
Adresse
8 DAVIS DRIVE, DURHAM
Vergleichen Sie IRD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRD
Opus Genetics Inc
|
1.07 | 65.63M | 8.38M | -27.19M | -13.59M | -1.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Opus Genetics Inc Stock (IRD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-11 | Eingeleitet | Craig Hallum | Buy |
| 2024-11-13 | Fortgesetzt | H.C. Wainwright | Buy |
Opus Genetics Inc Aktie (IRD) Neueste Nachrichten
Custom watchlist performance reports with Opus Genetics Inc.High Return Strategy with Low Risk - Newser
Is Opus Genetics Inc. stock reversal real or fakeFree Reversal Alert Based on RSI Indicator - Newser
Opus Genetics Inc. stock chart pattern explainedFree Chart Alert System With Entry Targets - Newser
Published on: 2025-08-08 22:54:28 - Newser
Price momentum metrics for Opus Genetics Inc. explainedFree Fundamental Growth Stock Analysis - Newser
How Opus Genetics Inc. stock reacts to Fed policy changesFast Movement Forecast for Trading Success - Newser
Using economic indicators to assess Opus Genetics Inc. potentialAI Generated Momentum Stock Forecast Guide - Newser
Opus Genetics Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Opus Genetics Inc. stock trend outlook and recovery pathReal Time Alert System for Market Moves - Newser
Will Opus Genetics Inc. price bounce be sustainableTechnical Reversal Pattern Summary and Tracker - Newser
What high frequency data says about Opus Genetics Inc.Free Stock Selection With High Accuracy - Newser
Opus Genetics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewswire
Gene Therapy Leader Opus Genetics Showcases Retinal Disease Breakthroughs at Major Ophthalmology Conference - Stock Titan
Sentiment analysis tools applied to Opus Genetics Inc.Historical Stock Summary and ROI Review - Newser
What are the technical indicators suggesting about Opus Genetics Inc.Discover breakthrough investment opportunities - Jammu Links News
What is the dividend policy of Opus Genetics Inc. stockUnlock daily market insights for better trades - Jammu Links News
When is Opus Genetics Inc. stock expected to show significant growthBuild wealth faster with consistent growth stocks - Jammu Links News
What are Opus Genetics Inc. company’s key revenue driversFind market-beating stocks for your portfolio - Jammu Links News
How does Opus Genetics Inc. compare to its industry peersCapitalize on fast-moving market trends - Jammu Links News
What drives Opus Genetics Inc. stock priceInvest smarter with actionable market insights - Jammu Links News
What markets is PRTS expanding into Is Opus Genetics Inc. stock a good long term investment optionUnlock powerful trading signals and alerts - Jammu Links News
What is the risk reward ratio of investing in Opus Genetics Inc. stockFree Stock Market Real-Time Monitoring - Jammu Links News
How volatile is Opus Genetics Inc. stock compared to the marketAchieve consistent double-digit growth - Jammu Links News
Should I hold or sell Opus Genetics Inc. stock in 2025Game-changing returns - Jammu Links News
What is Opus Genetics Inc. company’s growth strategySuperior stock selection - Jammu Links News
What are analysts’ price targets for Opus Genetics Inc. in the next 12 monthsAchieve rapid financial growth with smart picks - Jammu Links News
Why is Opus Genetics Inc. stock attracting strong analyst attentionMaximize returns with disciplined trading approaches - Jammu Links News
Why Opus Genetics Inc. stock attracts strong analyst attentionBuy Candidate Summary Based on Fundamentals - Newser
Is a relief rally coming for Opus Genetics Inc. holdersTen-Year Sector Performance and Summary Analysis - Newser
Pro Bono Team Advises Global RDH12 Alliance and Eyes on the Future in Collaboration with Opus Genetics to Advance Gene Therapy for Inherited Childhood Blindness - Legal Desire Media and Insights
Institutional scanner results for Opus Genetics Inc.Trade Safety Matrix for Conservative Traders - Newser
Can a trend reversal in Opus Genetics Inc. lead to recoveryFree Market Entry and Exit Point Tips - Newser
Will a bounce in Opus Genetics Inc. offer an exitSector Rotation Strategy for Smart Traders - Newser
Volatility clustering patterns for Opus Genetics Inc.Free Exit Ready Momentum Stock Watchlist - Newser
Opus Genetics and Global RDH12 Alliance announce partnership - Modern Retina
Tick level data insight on Opus Genetics Inc. volatilityHistorical Volatility and Pattern Breakdown Analysis - Newser
What makes Opus Genetics Inc. stock price move sharplyMachine Learning Intraday Signal Forecast - Newser
Finanzdaten der Opus Genetics Inc-Aktie (IRD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):